The 40-Gene Expression Profile Test Identifies Patients with National Comprehensive Cancer Network High-Risk Cutaneous Squamous Cell Carcinoma at High Risk of Poor Outcomes to Inform Management Decisions. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 4, p. 2426–2443, 2025. DOI: 10.25251/mvr2rn83. Disponível em: https://skin.dermsquared.com/skin/article/view/3561. Acesso em: 15 nov. 2025.